243 related articles for article (PubMed ID: 32971521)
21. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia type 1 (MEN1).
Carroll RW
Asia Pac J Clin Oncol; 2013 Dec; 9(4):297-309. PubMed ID: 23279763
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors.
Imamura M; Nakamoto Y; Uose S; Komoto I; Awane M; Taki Y
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):602-9. PubMed ID: 25624017
[TBL] [Abstract][Full Text] [Related]
24. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
25. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract][Full Text] [Related]
26. [Individualized approach for MEN1-associated duodenopancreatic neuroendocrine neoplasms].
Manoharan J; Albers MB; Bartsch DK
Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
[TBL] [Abstract][Full Text] [Related]
27. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Gibril F; Schumann M; Pace A; Jensen RT
Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
30. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
31. [Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients].
Balogh K; Hunyady L; Patócs A; Valkusz Z; Bertalan R; Gergics P; Majnik J; Toke J; Tóth M; Szucs N; Gláz E; Futo L; Horányi J; Rácz K; Tulassay Z
Orv Hetil; 2005 Oct; 146(43):2191-7. PubMed ID: 16323565
[TBL] [Abstract][Full Text] [Related]
32. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
Karges W; Schaaf L; Dralle H; Boehm BO
Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
[TBL] [Abstract][Full Text] [Related]
33. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
34. [Multiple endocrine neoplasia type 1: genetic and clinical aspects].
Calender A; Cadiot G; Mignon M
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B38-48. PubMed ID: 11449144
[No Abstract] [Full Text] [Related]
35. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
[TBL] [Abstract][Full Text] [Related]
36. Recent Topics Around Multiple Endocrine Neoplasia Type 1.
Marx SJ
J Clin Endocrinol Metab; 2018 Apr; 103(4):1296-1301. PubMed ID: 29897580
[TBL] [Abstract][Full Text] [Related]
37. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
38. Atypical clinical manifestations of multiple endocrine neoplasia type 1 syndrome.
Krysiak R; Kajdaniuk D; Marek B; Okopień B
Pol Arch Med Wewn; 2009 Mar; 119(3):175-9. PubMed ID: 19514648
[TBL] [Abstract][Full Text] [Related]
39. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1. I. Diagnosis].
Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2004 Mar; 129(12):630-3. PubMed ID: 15011133
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
